Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Kritika Sarmah

Edwards Lifesciences’ Quarterly Earnings Preview: What You Need to Know

Edwards Lifesciences Corporation (EW), a $39.4 billion medical technology firm based in Irvine, California, specializes in cutting-edge solutions for structural heart disease and critical care monitoring. Its product lineup includes tissue heart valves, valve repair systems, hemodynamic monitoring devices, angioscopy tools, oxygenators, and related pharmaceuticals. The company is slated to report its fiscal first-quarter earnings for FY2025 on Thursday, Apr. 24. 

Ahead of the event, analysts expect EW to report a profit of $0.60 per share on a diluted basis, down 9.1% from $0.66 per share in the year-ago quarter. The company beat or matched Wall Street’s EPS estimates in all of its last four quarterly reports. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.